Archives of Pharmacal Research

  • 제24권6호
  • /
  • Pages.572-577
  • /
  • 2001
  • /
  • 0253-6269(pISSN)
  • /
  • 1976-3786(eISSN)
대한약학회 (The Pharmaceutical Society of Korea)
권호 표지

Effect of Vehicles and Enhancers on the in vitro Skin Penetration of Aspalatone and Its Enzymatic Degradation Across Rat Skins

  • Gwak, Hye-Sun (Laboratory of Pharmaceutics, College of Pharmacy, Dongduk Women′s University) ;
  • Chun, In-Koo (Laboratory of Pharmaceutics, College of Pharmacy, Dongduk Women′s University)
  • 발행 : 2001.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

The feasibility of skin penetration was studied for aspalatone (AM, acetylsalicylic acid maltol ester), a novel antithrombotic agent. In this studys hairless mouse dorsal skins were used as a model to select composition of vehicle and AM. Based on measurements of solubility and partition coefficient, the concentration of PC that showed the highest flux for AM across the hairless mouse skin was found to be 40%. The cumulative amount permeated at 48 h, however, appear inadequate, even when the PC concentration was employed. To identify a suitable absorption enhancer and its optimal concentration for AM, a number of absorption enhancers and a variety of concentration were screened for the increase in transdermal flux of AM. Amongst these, linoleic acid (LOA) at the concentration of 5% was found to have the largest enhancement factor (i.e., 132). However, a further increase in AM flux was not found in the fatty acid concentration greater than 5%, indicating the enhancement effect is in a bell-shaped currie. In a study of the effect of AM concentration on the permeation, there was no difference in the permeation rate between 0.5 and 1% for AM, below its saturated concentration. At the donor concentration of 2%, over the saturated condition, the flux of AM was markedly increased. A considerable degradation of AM was found during permeation studies, and the extent was correlated with protein concentrations in the epidermal and serosal extracts, and skin homogenates. In rat dorsal skins, the protein concentration decreased in the rank order of skin homogenate > serosal extract > epidermal extract. Estimated first order degradation rate constants were $6.15{\pm}0.14,{\;}0.57{\pm}0.02{\;}and{\;}0.011{\pm}{\;}0.004{\;}h^{-1}$ for skin homogenate, serosal extract and epidermal extract, respectively. Therefore, it appeared that AM was hydrolyzed to some extent into salicylmaltol by esterases in the dermal and subcutaneous tissues of skin. taken together, our data indicated that transdermal delivery of AM is feasible when the combination of PC and LOA is used as a vehicle. However, since AM is not metabolically stable, acceptable degradation inhibitors may be nervessary to fully realize the transdermal delivery of the drug.

키워드

참고문헌

  1. Int. J. Pharm. v.33 Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides Aungst,B.J.;Rogers,N.J.;Shefter,E.
  2. Pharm. Res. v.7 Contributions of drug solubilization, partitioning, barrier disruption, and solvent permeation to the enhancement of skin permeation of various compounds with fatty acids and amines Aungst,B.J.;Blake,J.A.;Hussain,M.A.
  3. Circulation v.101 Aspirin [cardiovascular drug] Awtry,E.H.;Loscalzo,J.
  4. J. Contr. Res. v.6 Mode of action of penetration enhancers in human skin Barry,B.W.
  5. J. Kor. Pharm. Sci. v.31 Permeation and enzymatic degradation of aspalatone in gastrointestinal tract of rabbit Chun,I.K.;Gwak,H.S.
  6. Solution Behavior of Surfactants v.2 Effect of decylmethylsulfoxide on skin penetration Cooper,E.R.;K.L.Mittal(ed.);E.J.Fendler(ed.)
  7. J. Appl. Pharm. v.8 Preformulation study of aspalatone, a new antithrombotic agent Gwak,H.S.;Chun,I.K.
  8. Proc. Natl. Acad. Sci. v.82 Nasal absorption of insulin: enhancement by hydrophobic bile salts Gordon,G.S.;Moses,A.C.;Silver,R.D.;Flier,J.S.;Carey,M.C.
  9. Arzneim. Forsch. v.44 Synthesis and antiplatelet effects of the new antithrombotic agent aspalatone with low ulcerogenicity Han,B.H.;Suh,D.Y.;Ynag,H.O.;Park,Y.H.;Kang,Y.H.;Kim,Y.C.
  10. Int. J. Pharm. v.9 Mechanisms for the enhancement of the nasal absorption of insulin by surfactants Hirai,S.;Yashiki,T.;Mima,H.
  11. Biochem. Biophys. Acta. v.818 Effects of long-chain sic-unsaturated fatty acids and their alcohol analogues on aggregation of bovine platelets and their relation with membrane fluidity change Kitagawa,S.;Endo,J.;Kametani,F.
  12. Int. J. Pharm. v.181 Effect of ethanol/propylene glycol on the in vitro percutaneous absorption of aspirin, biophysical changes and macroscopic barrier properties of the skin Levang,A.K.;Zhao,K.;Singh,J.
  13. Nat. Struct. Biol. v.2 The structural basis of aspirin activity inferred from the crystal structure of inactivated prostaglandin H2 synthase Loll,P.J.;Picot,D.;Garavito,R.M.
  14. Chem. Pharm. Bull. v.38 Percutaneous absorption of indomethacin from mixtures of fatty alcohol and propylene glycol (FAPG bases) through rat skin: effects of oleic acid added to FAPG base Nomura,H.;Fusao,K.;Sugimoto,Y.;Miyashita,Y.;Dohi,M.;Kato,Y.
  15. J. Pharm. Sci. v.60 Significance of vehicle composition Ⅰ: Relationship between topical vehicle composition, skin penetrability, and clinical efficacy Ostrenga,J.;Steinmetz,C.;Poulsen,B.
  16. J. Clin. Invest. v.69 Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects Patrignani,P.;Filabozzi,P.;Patroco,C.
  17. N. Eng. J. Med. v.330 Aspirin as an antiplatelet drug Patrono,C.
  18. J. Clin. Invest. v.56 The mechanism of the effect of aspirin on human platelets I: acetylation of a particulate fraction protein Roth,G.J.;Majerus,P.W.
  19. J. Soc. Cosmet. Chem. v.21 Effects of surfactants and solvents on the permeability of epidermis Scheuplein,R.;Ross,L.
  20. Clin. Chem. v.33 Simple spectrophotometric determination of urinary albumin by dye-blinding with use of bromophenol blue Schosinsky,K.H.;Vargas,M.;Esquivel,A.L.;Chavarria,M.A.
  21. Arch. Pharm. Res. v.19 Maltol, an antioxidant component of Korean red ginseng, shows little prooxidant activity Suh,D.Y.;Han,Y.N.;Han,B.H.
  22. Pharm. Res. v.7 Bile salt-fatty acid mixed micelles as nasal absorption promoters of peptides. Ⅱ. In vivo nasal absorption of insulin in rats and effects of mixed micells on the morphological integrity of the nasal mucosa Tengamnuay,P.;Mitra,A.K.
  23. Chem. Pharm. Bull. v.35 Mechanism of enhancement of percutaneous absorption of molsidomine by oleic acid Yamada,M.;Uda,Y.;Tanigawara,Y.